Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
38 participants
INTERVENTIONAL
2014-07-10
2021-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to introduce in France an innovative technique for prenatal repair of myelomeningocele until now developed only on the American continent.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
In Utero Surgery for Fetal Myelomeningocele: Decision-making Mechanisms and Psychological Impact of Prenatal Therapy
NCT06796972
Risk Factors Associated With Spontaneous Preterm Delivery Status Post Open Fetal Myelomeningocele Repair
NCT03073382
Stress-associated Epigenetic Alterations in Newborns After Fetal Surgery
NCT04027374
Development of a Patient-reported Outcome Measure for Chiari Malformation and Syringomyelia
NCT06011226
Diffusion-weighted Cerebral MRI and Intra Uterine Growth Restriction.
NCT02229630
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The PRIUM study will include 10 cases of fetuses with prenatal diagnosis of SB and for whom the maternal willing will be to continue the pregnancy. A surgical prenatal repair of the defect will be planed at 19-25+6 weeks gestation following maternal laparotomy and hysterotomy under maternal general anesthesia. The delivery will be planed at 36 weeks'. Postnatal evaluation of the neonates will be scheduled at birth, 1 month, 12 months and 36 months of age. Those data will be matched to controls who have underwent a conventional postnatal repair of the SB
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
No prenatal surgical repair of myelomeningocele
No interventions assigned to this group
Case - open surgical repair
Prenatal surgical repair of fetal myelomeningocele
prenatal surgical repair of fetal myelomeningocele
open surgical repair of myelomeningocele before 26 weeks gestational age
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prenatal surgical repair of fetal myelomeningocele
open surgical repair of myelomeningocele before 26 weeks gestational age
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* A term between 19 and 25 +6 weeks gestational age (not for control)
* Single-Pregnancy
* Normal fetal karyotype
* Myelomeningocele with higher-level defect between S1 and T1
* Placenta not low-inserted or not covering
* Fault-isolated ultrasound reference
Exclusion Criteria
* Patient foreigner who understands not French
* Multiple Pregnancy
* Low Placenta inserted or covering
* Severe kyphosis
* Placental abruption
* Fetal malformation unrelated to the existence of myelomeningocele (the existence of a malposition of one or both feet do not represent an exclusion criterion)
* Increased risk of preterm birth: a history of preterm delivery before 37 weeks gestational age, cervical length \<26 mm before 26 weeks gestational age (not for control)
* Bleeding active between 20 and 26 weeks gestational age (not for control)
* Maternal obesity with BMI\> 35 (not for control)
* History of uterine surgery involving the anterior surface of the uterus (not for control)
* Maternal contradiction in surgery or general anesthesia (not for control)
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
URC-CIC Paris Descartes Necker Cochin
OTHER
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michel Zerah, MD, PhD
Role: STUDY_DIRECTOR
Assistance Publique - Hôpitaux de Paris
Jean-Marie Jouannic, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Armand Trousseau, APHP
Paris, PARIS, France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Friszer S, Dhombres F, Di Rocco F, Rigouzzo A, Garel C, Guilbaud L, Forin V, Moutard ML, Zerah M, Jouannic JM. [Preliminary results from the French study on prenatal repair for fetal myelomeningoceles (the PRIUM study)]. J Gynecol Obstet Biol Reprod (Paris). 2016 Sep;45(7):738-44. doi: 10.1016/j.jgyn.2015.09.002. Epub 2015 Nov 10. French.
Guilbaud L, Maurice P, Lallemant P, De Saint-Denis T, Maisonneuve E, Dhombres F, Friszer S, Di Rocco F, Garel C, Moutard ML, Lachtar MA, Rigouzzo A, Forin V, Zerah M, Jouannic JM. Open fetal surgery for myelomeningocele repair in France. J Gynecol Obstet Hum Reprod. 2021 Nov;50(9):102155. doi: 10.1016/j.jogoh.2021.102155. Epub 2021 Apr 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A00385-40
Identifier Type: REGISTRY
Identifier Source: secondary_id
P121103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.